Company profile

Guska

Designing viruses to fight cancer, powered by AI

Industry
Biotechnology Research
Employees
10
Headquarters
Montevideo
Founded
2024
Office locations
1

Guska company summary

Guska is a company in the Biotechnology Research industry, headquartered in Montevideo, founded in 2024. On LinkedIn the company has around 10 employees. Its listed specialties include oncology, therapies, oncolytic viruses, RNA technology, AI-biotech.

What technology does Guska use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Guska

Guska develops solutions based on synthetic RNA oncolytic virus therapy that have potent and safe immunostimulatory effects to address the pain point of cancer treatment by providing a targeted and less harmful alternative to traditional therapies. Our technology uses synthetic RNA viruses designed to safely reach and destroy cancer cells without affecting normal cells and promoting a robust immune response against tumor cells.

Specialties

oncologytherapiesoncolytic virusesRNA technologyAI-biotechAI-driven viruses

Where is Guska located?

Guska lists 1 location.

Montevideo, 11400, UYHQ
2020 Mataojo

Compare companies similar to Guska

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Guska
guska.bio
Biotechnology Research102024Montevideo
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Guska

What does Guska do?

Guska develops solutions based on synthetic RNA oncolytic virus therapy that have potent and safe immunostimulatory effects to address the pain point of cancer treatment by providing a targeted and less harmful alternative to traditional therapies. Our technology uses synthetic RNA viruses designed to safely reach and destroy cancer cells without affecting normal cells and promoting a robust immune response against tumor cells.

How many employees does Guska have?

Guska has around 10 employees on LinkedIn.

Where is Guska headquartered?

Guska is headquartered in Montevideo.

When was Guska founded?

Guska was founded in 2024.

Build a lead list from companies like Guska

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.